Press Releases

Jul 12, 2021

Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth

Read More

Jul 08, 2021

Veracyte to Release Second Quarter 2021 Financial Results on July 29, 2021

Read More

Jul 08, 2021

Veracyte Announces Key Appointments to Executive Leadership Team, Supporting Global Expansion

Read More

Jul 01, 2021

Veracyte Announces Two Pre-Eminent Physician Appointments, Further Strengthening Medical Team

Read More

Jun 14, 2021

New Data Published in JAMA Oncology Demonstrate Prognostic Utility of Veracyte’s Decipher Prostate Genomic Classifier in Locally Advanced Prostate Cancer

Read More

Jun 04, 2021

Veracyte Receives Final Medicare Coverage Policies for Decipher Bladder

Read More

Jun 02, 2021

Veracyte to Present at Upcoming Investor Conferences

Read More

Jun 01, 2021

Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth

Read More

May 26, 2021

Veracyte to Present at Upcoming Investor Conferences

Read More

May 26, 2021

Veracyte Announces New Data Demonstrating Afirma Xpression Atlas Identifies Clinically Relevant Gene Fusions in Thyroid Cancer FNA Samples

Read More